The company said that recent study results show its Aventa Lymphoma test can provide actionable information that would typically be missed by FISH testing.

NEW YORK – Diasorin reported on Wednesday that its third quarter revenues declined 2 percent year over year as volume-based procurement regulations took effect in China, COVID-19-related sales ...

NEW YORK – The Association for Diagnostics & Laboratory Medicine (ADLM) on Tuesday issued guidelines on coagulation testing in patients taking blood thinners that could interfere with the results of ...

Note: This story previously stated the xM test was licensed from Personalis, instead of the xM NeXT test. We regret the error. NEW YORK – With Medicare ...

Revenues from the Life Sciences business unit, which is on track to be sold to Waters in Q1 2026, rose 2 percent to $1.37 billion.

NEW YORK – BioMérieux announced Tuesday that its third quarter revenues decreased 2 percent, impacted by low respiratory infection epidemiology and lower sales in China. For the three months ended ...

Parent firm Siemens is considering reducing its ownership stake in Siemens Healthineers, which could mean the termination of existing financing agreements.

The firm said that growth in its immunodiagnostics business was offset by contraction in its molecular diagnostics, licensed technologies, and COVID-19 businesses.

NEW YORK — Swedish diagnostics maker Devyser said on Tuesday that its next-generation sequencing-based cystic fibrosis test has received certification under Europe's In Vitro Diagnostic Regulation ...

For the fourth quarter, the point-of-care diagnostics company anticipates revenues of between $25 million and $28 million.

Third quarter revenues dipped 4 percent as reported but rose 5 percent excluding results from COVID-19 testing and the donor screening business the firm is exiting.